Sub-Total: $0.00
Emerging Strategies in the Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) or its Receptor in the Preventive Treatment of Migraine
Complimentary
Related products
-
Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more -
Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis
Read more -
New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Read more
